Shopify helps customers build online shops, but it’s minting tech founders and investors, too
Last month, Jean-Michel Lemieux, the chief technology officer of Shopify, and the company’s chief talent officer, Brittany Forsyth, both announced that they are stepping down from their roles. Chief legal officer Joe Frasca is also set to step down, with all three ending their tenures next month. In their next chapters, all seem keen to advise, invest in or even launch startups, joining a growing number of former Shopify executives and employees to do the same.
For an enterprise of Shopify’s size the 15-year-old, 7,000-person, Ottawa-based outfit boasts a $130 billion market cap that’s not a surprise. Still, because of the vast wealth that Shopify has helped create, and its focus on sustainability among other things it invests $5 million per year in startups that fight climate change and publishes annual sustainability reports its former employees look to have an impact
Share this article
MONTRÉAL, Jan. 21, 2021 /PRNewswire/ -
Eli, a company enabling women to own their fertility and health decisions with a novel hormone tracking technology, today announced its $1.5 million USD seed round co-led by Vectr Ventures and 2048 Ventures. The round closed in December 2020 with the participation of Real Ventures, Techstars, Panache Ventures, Ramen Ventures, MEDTEQ+, and serial entrepreneur Steven Arless, who also joined the board.The round brings the company s total funding since its creation in mid-2019 to $2.1 million USD. This amount includes a previous investment from Techstars and Real Ventures via Techstars Montréal AI. Hormones are core to women s fertility and general health, yet they remain a black box. We are unlocking that box and empowering women to have access to their own hormone data daily,
Eli raises $1.9 million CAD in seed funding to develop at-home hormone monitoring tech
Eli Science Inc. has raised a $1.9 million CAD ($1.5 million USD) seed round to target the historically underserved women’s healthtech market via its saliva-based daily hormone tracking technology.
The round, which was co-led by Hong Kong’s Vectr Ventures and 2048 Ventures, closed in late December 2020. Other investors included Real Ventures, Techstars, Panache Ventures, Ramen Ventures, MEDTEQ+, and Steven Arless, who joined Eli Health’s board of directors. To date, the company has raised a total of $2.1 million USD, including prior investments from Techstars and Real Ventures through Techstars Montreal AI accelerator.